Divi's Laboratories Limited (DIVISLAB) Stock Statistics & Valuation Metrics

Divi's Laboratories Limited has a market cap or net worth of ₹1.81T. The enterprise value is ₹1.76T.

Divi's Laboratories Limited has 265,468,570 shares outstanding. The number of shares has decreased by -2.65% in one year.

Divi's Laboratories Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.55%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Divi's Laboratories Limited had revenue of 78.45B and earned 16.00B in profits. Earnings per share was 60.27.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Divi's Laboratories Limited pays an annual dividend of ₹30, resulting in a dividend yield of 0.44%

Divi's Laboratories Limited upcoming earnings date is Aug 11, 2025, TBA (Confirmed).

Divi's Laboratories Limited as a current ratio of 7.57, with Debt / Equity ratio of 0.03%

In the past 12 months, Divi's Laboratories Limited has paid 5.63B in taxes.

Divi's Laboratories Limited EV to EBITDA ratio is 37.11, with an EV/FCF ratio of 365.73.

Divi's Laboratories Limited has ₹37.31B in cash and marketable securities with ₹40.00M in debt, giving a net cash position of -₹37.27B billion.

Gross margin is 56.05%, with operating margin of 23.35%, and net profit margin of 20.40%.

The average price target for Divi's Laboratories Limited is ₹6,641.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy